Alcohol
Volume 46, Issue 1 , Pages 17-27 , February 2012

Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats

  • Ronnie Dhaher

      Affiliations

    • Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
    • Corresponding Author InformationCorresponding author. Department of Laboratory Medicine, Yale University School of Medicine, 330 Cedar Street CB 438, New Haven, CT 06520-8035, USA. Tel.: +1-317-430-6257; fax: +1-203-785-2236.
    • ,
  • Jamie E. Toalston

      Affiliations

    • Department of Psychiatry, Institute of Psychiatric Research, Indiana School of Medicine, Indiana University, Indianapolis, IN 46202, USA
    • Department of Psychology, Purdue School of Science, Indiana University-Purdue University at Indianapolis, Indianapolis, IN 46202, USA
    • ,
  • Sheketha R. Hauser

      Affiliations

    • Department of Psychiatry, Institute of Psychiatric Research, Indiana School of Medicine, Indiana University, Indianapolis, IN 46202, USA
    • ,
  • Richard L. Bell

      Affiliations

    • Department of Psychiatry, Institute of Psychiatric Research, Indiana School of Medicine, Indiana University, Indianapolis, IN 46202, USA
    • Department of Psychology, Purdue School of Science, Indiana University-Purdue University at Indianapolis, Indianapolis, IN 46202, USA
    • ,
  • David L. McKinzie

      Affiliations

    • Neuroscience Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA
    • ,
  • William J. McBride

      Affiliations

    • Department of Psychiatry, Institute of Psychiatric Research, Indiana School of Medicine, Indiana University, Indianapolis, IN 46202, USA
    • Department of Biochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    • ,
  • Zachary A. Rodd

      Affiliations

    • Department of Psychiatry, Institute of Psychiatric Research, Indiana School of Medicine, Indiana University, Indianapolis, IN 46202, USA
    • Department of Psychology, Purdue School of Science, Indiana University-Purdue University at Indianapolis, Indianapolis, IN 46202, USA

Received 5 November 2009 ,Revised 25 August 2011 ,Accepted 25 August 2011.

References 

  1. Akala EO, Wang H, Adedoyin A. Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats. Neuropsychobiology. 2008;58:81–90
  2. Anton RF. What is craving? Models and implications for treatment. Alcohol Res. Health. 1999;23:165–173
  3. Assanangkornchai S, Srisurapanont M. The treatment of alcohol dependence. Curr. Opin. Psychiatry. 2007;20:222–227
  4. Bäckström P, Hyytiä P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol. Clin. Exp. Res. 2004;28:558–565
  5. Badia-Elder NE, Mosemiller AK, Elder RL, Froehlich JC. Naloxone retards the expression of a genetic predisposition toward alcohol drinking. Psychopharmacology. 1999;144:205–212
  6. Bespalov AY, Tokarz ME, Bowen SE, Balster RL, Beardsley PM. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice. Psychopharmacology. 1999;141:118–122
  7. Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol. Clin. Exp. Res. 1998;22:359–366
  8. Burattini C, Gill TM, Aicardi G, Janak PH. The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience. 2006;139:877–887
  9. Ciccocioppo R, Lin D, Martin-Fardon R, Weiss F. Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology. 2003;168:208–215
  10. Ciccocioppo R, Martin-Fardon R, Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology. 2002;27:391–399
  11. Cowen MS, Rezvani AH, Jarrott B, Lawrence AJ. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density. Alcohol. Clin. Exp. Res. 1999;23:1008–1014
  12. Czachowski CL, Delory MJ. Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats. Psychopharmacology. 2009;204:335–348
  13. Dayas CV, Liu X, Simms JA, Weiss F. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol. Psychiatry. 2007;61:979–989
  14. Domjan M, Burkhard B. The Principles of Learning and Behavior. Monterey, CA: Brooks Cole Publishing; 1982;
  15. Emmerson PJ, McKinzie JH, Surface PL, Suter TM, Mitch CH, Statnick MA. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists. Eur. J. Pharmacol. 2004;494:121–130
  16. Escher T, Mittleman G. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addict. Biol. 2006;11:55–63
  17. Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, et al. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites. Neuropeptides. 2005;39:559–567
  18. Gilpin NW, Richardson HN, Koob GF. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008;32:1535–1542
  19. Grahame NJ, Mosemiller AK, Low MJ, Froehlich JC. Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis. Pharmacol. Biochem. Behav. 2000;67:759–766
  20. Häggkvist J, Lindholm SF. J The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict. Biol. 2009;14:260–269
  21. Heyser CJ, Moc K, Koob GF. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology. 2003;28:1463–1471
  22. Hölter SM, Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology. 1999;145:360–369
  23. Ji D, Gilpin NW, Richardson HN, Rivier CL, Koob GF. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav. Pharmacol. 2008;19:1–12
  24. Kamdar NK, Miller SA, Syed YM, Bhayana R, Gupta T, Rhodes JS. Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology. 2007;192:207–217
  25. Kiefer SW, Hill KG, Coonfield DL, Ferraro FM. Ethanol familiarity and naltrexone treatment affect ethanol responses in rats. Alcohol. 2005;37:167–172
  26. Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry Clin. Neurosci. 2004;58:30–36
  27. Koistinen M, Tuomainen P, Hyytiä P, Kiianmaa K. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. Alcohol. Clin. Exp. Res. 2001;25:1605–1612
  28. Kornet M, Goosen C, Van Ree JM. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology. 1991;104:367–376
  29. Krishnan-Sarin S, Krystal JH, Shi J, Pittman B, O’Malley SS. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol. Psychiatry. 2007;62:694–697
  30. Kuzmin A, Kreek MJ, Bakalkin G, Liljequist S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology. 2007;32:902–910
  31. Kuzmin A, Stenback T, Liljequist S. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption. Eur. J. Pharmacol. 2008;584:352–356
  32. Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology. 1999;21:435–444
  33. Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 2002;22:7856–7861
  34. Macintosh NJ. Stimulus control: attentional factors. In:  Honig WK,  Staddon JER editor. Handbook on Operant Behavior. Englewood Cliffs, NJ: Prentice-Hall; 1977;p. 162–241
  35. Marczak ED, Jinsmaa Y, Li T, Bryant SD, Tsuda Y, Okada Y, et al. [N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties. J. Pharmacol. Exp. Ther. 2007;323:374–380
  36. Marinelli PW, Funk D, Juzytsch W, Li Z, Lê AD. Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur. J. Neurosci. 2007;26:2815–2823
  37. Mhatre M, Pruthi R, Hensley K, Holloway F. 5-HT3 antagonist ICS 205-930 enhances naltrexone’s effects on ethanol intake. Eur. J. Pharmacol. 2004;491:149–156
  38. Mitchell JM, Bergren LJ, Chen KS, Rowbotham MC, Fields HL. Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiol. Dis. 2009;33:72–80
  39. Modesto-Lowe V, Fritz EM. The opioidergic-alcohol link: implications for treatment. CNS Drugs. 2005;19:693–707
  40. Mormede P, Colas A, Jones BC. High ethanol preferring rats fail to show dependence following short- or long-term ethanol exposure. Alcohol Alcohol. 2004;39:183–189
  41. Myers RD, Borg S, Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 1986;3:383–388
  42. Oliva JM, Manzanares J. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats. Neuropsychopharmacology. 2007;32:1358–1369
  43. O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry. 1992;49:881–887
  44. Oswald LM, Wand GS. Opioids and alcoholism. Physiol. Behav. 2004;81(2):339–358
  45. Parker LA, Rennie M. Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol. Biochem. Behav. 1992;41:559–565
  46. Pavlov IP. Conditioned Reflexes (G.V. Anrep trans). London: Oxford University Press; 1927;
  47. Pellicano MP, Sadile AG. Differential alcohol drinking behaviour and dependence in the Naples low- and high-excitability rat lines. Behav. Brain Res. 2006;171:199–206
  48. Pettinati HM, O’Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychopharmacol. 2006;26:610–625
  49. Pickering C, Liljequist S. Cue-induced behavioural activation: a novel model of alcohol craving?. Psychopharmacology. 2003;168:307–313
  50. Rezvani AH, Overstreet DH, Levin ED, Rosenthal DI, Kordik CP, Reitz AB, et al. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats. Alcohol. Clin. Exp. Res. 2007;31:57–63
  51. Rezvani AH, Overstreet DH, Vaidya AH, Zhao B, Levin ED. Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats. Alcohol. Clin. Exp. Res. 2009;33:1366–1373
  52. Rodd ZA, Bell RL, Sable HJ, Murphy JM, McBride WJ. Recent advances in animal models of alcohol craving and relapse. Pharmacol. Biochem. Behav. 2004;79:439–450
  53. Rodd ZA, Bell RL, Zhang Y, Murphy JM, Goldstein A, Zaffaroni A, et al. Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology. 2005;30:330–338
  54. Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, et al. The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav. Brain Res. 2006;171:207–215
  55. Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, et al. Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure. Alcohol. Clin. Exp. Res. 2002;26:1642–1652
  56. Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, et al. Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure. Alcohol. Clin. Exp. Res. 2002;26:1632–1641
  57. Rösner S, Leucht S, Lehert P, Soyka M. Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J. Psychopharmacol. 2008;22:11–23
  58. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology. 2006;189:175–186
  59. Sable HJ, Bell RL, Rodd ZA, McBride WJ. Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats. Int. J. Adolesc. Med. Health. 2006;18:139–149
  60. Sinclair JD, Senter RJ. Increased preference for ethanol in rats following deprivation. Psychon. Sci. 1967;8:11–12
  61. Sinclair JD, Senter RJ. Development of an alcohol-deprivation effect in rats. Q.J. Stud. Alcohol. 1968;29:863–867
  62. Spanagel R, Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol. Sci. 2008;29:109–115
  63. Statnick MA, Tinsley FC, Eastwood BJ, Suter TM, Mitch CH, Heiman ML. Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003;284:1399–1408
  64. Swanson SP, Catlow J, Pohland RC, Chay SH, Johnson T. Disposition of the opioid antagonist, LY255582, in rats and dogs. Drug Metab. Dispos. 1995;23:916–921
  65. Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R, McGeary JE, et al. Moderators of naltrexone’s effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol. Clin. Exp. Res. 2008;32:58–66
  66. Toalston JE, Oster SM, Kuc KA, Pommer TJ, Murphy JM, Lumeng L, et al. Effects of alcohol and saccharin deprivations on concurrent ethanol and saccharin operant self-administration by alcohol-preferring (P) rats. Alcohol. 2008;42:277–284
  67. Walker BM, Koob GF. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology. 2008;33:643–652
  68. Wang D, Raehal KM, Bilsky EJ, Sadée W. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J. Neurochem. 2001;77:1590–1600
  69. Wang D, Sun X, Sadee W. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment. J. Pharmacol. Exp. Ther. 2007;321:544–552
  70. White DA, Hwang ML, Holtzman SG. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol. Biochem. Behav. 2005;81:451–458
  71. Williams KL, Schimmel JS. Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment. Alcohol. 2008;42:553–563
  72. Williams KL, Winger G, Pakarinen ED, Woods JH. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology. 1998;139:53–61
  73. Williams KL, Woods JH. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcohol. Clin. Exp. Res. 1999;23:708–715
  74. Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone. Physiol. Behav. 2008;93:1005–1010

PII: S0741-8329(11)00462-9

doi: 10.1016/j.alcohol.2011.08.011

Alcohol
Volume 46, Issue 1 , Pages 17-27 , February 2012

Article Tools

* Image Usage & Resolution